NCT00193336View on ClinicalTrials.gov

Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

September 30, 2005

Conditions
Lung Cancer
Interventions
DRUG

ZD1839

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER